- Report
- July 2023
- 104 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- April 2024
- 132 Pages
Global
From €830EUR$950USD£721GBP
- Report
- November 2021
- 600 Pages
Global
From €3493EUR$4,000USD£3,035GBP
Patient Controlled Analgesia (PCA) is a form of analgesic therapy that allows patients to self-administer medication to manage their pain. It is typically used in the hospital setting, and involves the patient using a device to deliver a predetermined dose of medication when needed. The device is programmed to deliver a certain amount of medication over a certain period of time, and the patient can press a button to receive an additional dose if needed. This allows the patient to have more control over their pain management, and can help reduce the risk of opioid-related side effects.
The PCA market is a subset of the analgesics market, and is growing as more healthcare providers recognize the benefits of this type of therapy. Companies in this market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, and Smiths Medical. Show Less Read more